The problem of risk assessment and prophylaxis of venous thromboembolism in pregnancy

• References

• 1 Kruithof EK, Tran-Thang C, Gudinchet A. et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987; 69: 460-466.
• 2 Heit JA, Kobbervig CE, James AH. et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005; 143: 697-706.
• 3 Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996; 335: 108-114.
• 4 Dilley A, Austin H, El-Jamil M. et al. Genetic factors associated with thrombosis in pregnancy in a United States population. Am J Obstet Gynecol 2000; 183: 1271-1277.
• 5 James AH, Jamison MG, Brancazio LR. et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194: 1311-1315.
• 6 Arias E, Anderson RN, Kung HC. et al. Deaths: final data for 2001. Natl Vital Stat Rep 2003; 52: 1-115.
• 7 Welsch H, Krone HA, Wisser J. Maternal mortality in Bavaria between 1983 and 2000. Am J Obstet Gynecol 2004; 191: 304-308.
• 8 Robertson L, Greer I. Thromboembolism in pregnancy. Curr Opin Obstet Gynecol 2005; 17: 113-116.
• 9 Stein PD, Hull RD, Kayali F. et al. Venous thromboembolism in pregnancy: 21-year trends. Am J Med 2004; 117: 121-125.
• 10 Lee RV. Thromboembolism in pregnancy: a continuing conundrum. Ann Intern Med 2005; 143: 749-750.
• 11 Bates SM, Greer IA, Hirsh J. et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl. 03) 627S-644S.
• 12 Royal College of Obstetricians and Gynaecologists.. Thromboprophylaxis during pregnancy, labour and after vaginal delivery. Guideline No. 37. London:: RCOG Press;; 2004
• 13 Bauersachs R, Dudenhausen J, Faridi A. et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007; 98: 1237-1245.